A Molecular Take on Malignant Rhabdoid Tumors. Tang, M. & Verhaak, R. G. Trends Cancer, 2(5):217-218, 2016. 2405-8033 Tang, Ming Verhaak, Roel Gw P01 CA085878/CA/NCI NIH HHS/United States R01 CA190121/CA/NCI NIH HHS/United States Comment Journal Article United States 2016/09/28 Trends Cancer. 2016 May;2(5):217-218. doi: 10.1016/j.trecan.2016.04.003.doi abstract bibtex The molecular basis for the clinical heterogeneity observed in patients with malignant rhabdoid tumors is unknown. Recently, two reports revealed molecular inter-tumor heterogeneity in teratoid/rhabdoid tumors (ATRTs) and extra-cranial MRTs (ecMRTs) using genomic, transcriptomic and epigenomic profiling. Distinct molecular subgroups were identified and new therapeutic targets were revealed.
@article{RN6122,
author = {Tang, M. and Verhaak, R. G.},
title = {A Molecular Take on Malignant Rhabdoid Tumors},
journal = {Trends Cancer},
volume = {2},
number = {5},
pages = {217-218},
note = {2405-8033
Tang, Ming
Verhaak, Roel Gw
P01 CA085878/CA/NCI NIH HHS/United States
R01 CA190121/CA/NCI NIH HHS/United States
Comment
Journal Article
United States
2016/09/28
Trends Cancer. 2016 May;2(5):217-218. doi: 10.1016/j.trecan.2016.04.003.},
abstract = {The molecular basis for the clinical heterogeneity observed in patients with malignant rhabdoid tumors is unknown. Recently, two reports revealed molecular inter-tumor heterogeneity in teratoid/rhabdoid tumors (ATRTs) and extra-cranial MRTs (ecMRTs) using genomic, transcriptomic and epigenomic profiling. Distinct molecular subgroups were identified and new therapeutic targets were revealed.},
keywords = {malignant rhabdoid tumors
molecular analysis
pediatric cancer
sequencing},
ISSN = {2405-8033 (Print)
2405-8025},
DOI = {10.1016/j.trecan.2016.04.003},
year = {2016},
type = {Journal Article}
}
Downloads: 0
{"_id":"7PYqHj6zLHk2buRbj","bibbaseid":"tang-verhaak-amoleculartakeonmalignantrhabdoidtumors-2016","authorIDs":["5dce3b23dcea22df0100007c","5dec52fce16431f2010000c9","5dec5944e16431f2010000fa","5e0a5e7ace3ebce40100010e","5e2ff5be5bfc8ede0100003b","c8zrScQz6casKGL4t"],"author_short":["Tang, M.","Verhaak, R. G."],"bibdata":{"bibtype":"article","type":"Journal Article","author":[{"propositions":[],"lastnames":["Tang"],"firstnames":["M."],"suffixes":[]},{"propositions":[],"lastnames":["Verhaak"],"firstnames":["R.","G."],"suffixes":[]}],"title":"A Molecular Take on Malignant Rhabdoid Tumors","journal":"Trends Cancer","volume":"2","number":"5","pages":"217-218","note":"2405-8033 Tang, Ming Verhaak, Roel Gw P01 CA085878/CA/NCI NIH HHS/United States R01 CA190121/CA/NCI NIH HHS/United States Comment Journal Article United States 2016/09/28 Trends Cancer. 2016 May;2(5):217-218. doi: 10.1016/j.trecan.2016.04.003.","abstract":"The molecular basis for the clinical heterogeneity observed in patients with malignant rhabdoid tumors is unknown. Recently, two reports revealed molecular inter-tumor heterogeneity in teratoid/rhabdoid tumors (ATRTs) and extra-cranial MRTs (ecMRTs) using genomic, transcriptomic and epigenomic profiling. Distinct molecular subgroups were identified and new therapeutic targets were revealed.","keywords":"malignant rhabdoid tumors molecular analysis pediatric cancer sequencing","issn":"2405-8033 (Print) 2405-8025","doi":"10.1016/j.trecan.2016.04.003","year":"2016","bibtex":"@article{RN6122,\n author = {Tang, M. and Verhaak, R. G.},\n title = {A Molecular Take on Malignant Rhabdoid Tumors},\n journal = {Trends Cancer},\n volume = {2},\n number = {5},\n pages = {217-218},\n note = {2405-8033\nTang, Ming\nVerhaak, Roel Gw\nP01 CA085878/CA/NCI NIH HHS/United States\nR01 CA190121/CA/NCI NIH HHS/United States\nComment\nJournal Article\nUnited States\n2016/09/28\nTrends Cancer. 2016 May;2(5):217-218. doi: 10.1016/j.trecan.2016.04.003.},\n abstract = {The molecular basis for the clinical heterogeneity observed in patients with malignant rhabdoid tumors is unknown. Recently, two reports revealed molecular inter-tumor heterogeneity in teratoid/rhabdoid tumors (ATRTs) and extra-cranial MRTs (ecMRTs) using genomic, transcriptomic and epigenomic profiling. Distinct molecular subgroups were identified and new therapeutic targets were revealed.},\n keywords = {malignant rhabdoid tumors\nmolecular analysis\npediatric cancer\nsequencing},\n ISSN = {2405-8033 (Print)\n2405-8025},\n DOI = {10.1016/j.trecan.2016.04.003},\n year = {2016},\n type = {Journal Article}\n}\n\n","author_short":["Tang, M.","Verhaak, R. G."],"key":"RN6122","id":"RN6122","bibbaseid":"tang-verhaak-amoleculartakeonmalignantrhabdoidtumors-2016","role":"author","urls":{},"keyword":["malignant rhabdoid tumors molecular analysis pediatric cancer sequencing"],"metadata":{"authorlinks":{"verhaak, r":"https://verhaaklab.com/publications/bib/"}},"downloads":0},"bibtype":"article","biburl":"https://verhaaklab.com/files/verhaak.bib","creationDate":"2019-11-15T05:44:04.117Z","downloads":0,"keywords":["malignant rhabdoid tumors molecular analysis pediatric cancer sequencing"],"search_terms":["molecular","take","malignant","rhabdoid","tumors","tang","verhaak"],"title":"A Molecular Take on Malignant Rhabdoid Tumors","year":2016,"dataSources":["iFXeF2qjAL2y5TeTz"]}